IGI Logo

Tatva Chintan Pharma Chem Ltd. makes a strong debut on the bourses with scrip got listed at Rs 2,111.80 on the Bombay Stock Exchange, a 94.99 per cent premium to its issue price of Rs 1,083.00. On the National Stock Exchange, the stock was listed at Rs 2,111.85. The company, which raised 0.46 Cr from initial public offering, was subscribed 126.15 times, receiving bids for 5,824.10 lakhs shares against the total issue size of 46.17 lakhs shares. The company, listed under B Group Securities post its IPO, opened for subscription from Jul 16 to Jul 20.

Following a strong opening, the scrip touched an intraday high of Rs [BSEHighPrice] and a low of Rs [NSEHighPrice], before closing the session [UpDown] by [ChangePer] per cent to its listing price at Rs [ClosingPriceBSE] on the BSE. The company anticipates using the proceeds of the issue for Funding capital expenditure requirements for expansion of the Dahej Manufacturing Facility Funding capital expenditure requirements for upgradation at the R&D facility in Vadodara General corporate purposes. JM Financial Ltd.,ICICI Securities Ltd as lead managers & Link Intime India Private Limited is the registrar, to the issue. Meanwhile, the broader benchmark BSE Sensex closed trade at 52,443.71, down 135.05 points, or 0.25 per cent.